Dr Audrey-Flore Ngomsik

Over the past decade, while we were all watching these conferences with varying degrees of scepticism, something shifted. COP decisions stopped being theoretical and started showing up as line items on P&L statements. Some companies figured out how to profit from this. Others are still treating sustainability as a PR department problem. This is the story of what actually happened when climate diplomacy met quarterly reporting.

Climate change isn’t just melting ice caps—it’s raising women’s cancer risks. A new study links every 1°C rise in temperature to higher rates of breast, ovarian, uterine, and cervical cancers. As a CSR strategist, I argue this isn’t just a health issue—it’s a justice issue. Climate, gender, and health are colliding, and women are paying the price. It’s time to treat climate action as women’s health policy, and women’s health as climate strategy.

Here's a terrifying fact: Your immune system is powerful enough to destroy you. Every day, it's scanning for threats, ready to unleash cellular warfare. The 2025 Nobel Prize in Medicine went to three scientists who discovered why it doesn't: regulatory T cells, the peacekeepers that prevent your immune system from attacking your own body. Their breakthrough launched cancer treatments and autoimmune therapies but took 30 years to win recognition.